Ajax-Loading

Sumitomo Dainippon Pharma Co Ltd - Change In Working Capital

Sumitomo Dainippon Pharma Co Ltd's Fiscal Year is From April To March - All Figures are in JPY, Billions.

The item "Change-In-Working-Capital" stands at -37.53 Billion Japanese Yens for the trailing twelve months (TTM) period ending 09/30/2025, the lowest value since 09/30/2024.

Sumitomo Dainippon Pharma Co Ltd's second quarter result of -19.55 Billion JPY for the item "Change In Working Capital" represents a decrease of -12.16 percent compared to it's first quarter result.

Also, Sumitomo Dainippon Pharma Co Ltd's second quarter result of -19.55 Billion JPY for the item "Change In Working Capital" represents a decrease of -133.05 percent compared to it's second quarter result of last year.

Looking again at the trailing twelve months series (TTM), Sumitomo Dainippon Pharma Co Ltd's second quarter result of -37.53 Billion JPY for the item "Change In Working Capital" represents a decrease of -191.15 percent compared to it's first quarter result.


Regarding the One-Year-Change of the series, the current value constitutes an decrease of -37.38 Billion Japanese Yens compared to the value the year prior.
The 1 year change is -37.38 Billion Japanese Yens.
The 3 year change is -62.44 Billion Japanese Yens.
The 5 year change is -12.70 Billion Japanese Yens.

The Serie's long term average value is -0.446 Billion Japanese Yens. It's latest available value, on 09/30/2025, is -37.08 Billion Japanese Yens lower, compared to it's long term average value.
The Serie's change in Japanese Yens from it's minimum value, on 12/31/2023, to it's latest available value, on 09/30/2025, is +17.39 Billion.
The Serie's change in Japanese Yens from it's maximum value, on 03/31/2021, to it's latest available value, on 09/30/2025, is -103.86 Billion.

Change In Working Capital for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Change In Working Capital905,699,262,464.00
LogoJohnson & Johnson - Change In Working Capital486,508,953,600.00
LogoAbbVie Inc - Change In Working Capital399,570,305,024.00
LogoRoche Holding AG - Change In Working Capital317,433,206,677.55
LogoAstraZeneca PLC - Change In Working Capital280,205,508,085.11